Trial
NCT05281094
Efficacy and Safety of Two Doses of HIL-214 in Children
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
HilleVax
Collaborators
—
Condition
Gastroenteritis
Intervention
HIL-214
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-10